The Caspian Group
  • Home
  • About Us
    • Mission & Vision
    • Team
    • Contact Us
    • FAQs
  • Donation Programmes
    • Become a Donor
    • Become a Donee
  • News
    • Technology, Media & Telecommunications
    • Equities, Currencies & Foreign Exchange
    • Business Deals & International Trade
    • Market Roundup
  • Consultancy
    • Consultancy Services
    • Register your Interest

Business Deals & International Trade

Categories

All
Brazil
India
Spain
United Kingdom

Archives

May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021

Tata Steel acquisitions & Indian government vaccination purchases

8/21/2021

0 Comments

 
Picture
Picture
Tata Steel has expressed interest in acquiring RINL and NINL
Tata Steel, India's largest steelmaker, is interested in buying Rashtriya Ispat Nigam Limited (RINL). In Visakhapatnam, Andhra Pradesh, RINL, which is part of the steel ministry, owns and manages a 7.3 million tonnes factory. It is India's first integrated steel factory that is located on the shore.

When asking Narendarn, the CEO and Managing director of RINL about the interest tata steel has in for RINL, he replied with “Yes! Also, because for inorganic growth for long product opportunities... There is a great opportunity because it is a coastal plant so there are many advantages.”

RINL owns around 22,000 acres of land and has access to Gangavaram Port, which receives raw materials such as coking coal and other commodities. Because RINL is located on India's eastern coast, the acquisition will allow Tata Steel to expand its foothold in Southeast Asian markets, where it already has a presence.

Tata Steel has also submitted an Expression of Interest (EoI) for Odisha-based steelmaker Neelachal Ispat Nigam Ltd (NINL), according to the CEO. MMTC, National Mineral Development Corporation (NMDC), Bharat Heavy Electricals Ltd (BHEL), and MECON are all part of NINL, which is a joint venture firm.

Indian government is in talks to purchase 50 million vaccination doses from Pfizer
According to the Wall Street Journal, India is in talks to buy 50 million doses of Pfizer and German partner BioNTech SE's COVID-19 vaccinations. Pfizer did not immediately react to a request for comment from Reuters, and is claimed to have yet to seek clearance for the use of its vaccine in India, according to a Reuters article. India also expects to get roughly seven million doses of a vaccine produced by Moderna Inc. from the United States through Covax, a programme that distributes Covid-19 vaccinations to developing countries.

Written By: Kovid Gopikaramanan
Edited By: Ronojoy Borpujari

0 Comments



Leave a Reply.

    Archives

    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021

    Categories

    All
    Brazil
    India
    Spain
    United Kingdom

    RSS Feed

All Rights Reserved. The Caspian Group 2021. 
  • Home
  • About Us
    • Mission & Vision
    • Team
    • Contact Us
    • FAQs
  • Donation Programmes
    • Become a Donor
    • Become a Donee
  • News
    • Technology, Media & Telecommunications
    • Equities, Currencies & Foreign Exchange
    • Business Deals & International Trade
    • Market Roundup
  • Consultancy
    • Consultancy Services
    • Register your Interest